Complications MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL probably leads to lower complications MCID: 3% absolute difference compared with PCNL (moderate certainty).
1 finding from 1 review
Retreatment · people (>14 years) with kidney stones
ESWL may leads to higher retreatment rate MCID: 3% absolute difference compared with PCNL (low certainty).
1 finding from 1 review
Auxiliary procedures rate MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL probably leads to higher auxiliary procedures rate MCID: 3% absolute difference compared with PCNL (moderate certainty).
1 finding from 1 review
Duration of hospital stay MCID: 1 day absolute difference · people (>14 years) with kidney stones
1 finding from 1 review
Treatment success rate · people (>14 years) with kidney stones
ESWL may leads to lower treatment success rate at 3 months MCID: 5% absolute difference compared with RIRS (low certainty).
1 finding from 1 review
Quality of life MCID varies by instrument. · people (>14 years) with kidney stones
1 finding from 1 review
Complications MCID: 3% absolute difference · people (>14 years) with kidney stones
It is very uncertain whether ESWL changes complications MCID: 3% absolute difference compared with RIRS (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality (death from any cause)
The intervention showed no clear difference in all‐cause mortality (death from any cause) (high certainty).
1 finding from 1 review
Intervention not reported
Severe hypoglycaemic episodes (number of severe hypoglycaemic episodes)
The intervention may leads to higher severe hypoglycaemic episodes (number of severe hypoglycaemic… (low certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular events (incidents that may cause damage to the cardiovascular system)
The intervention may leads to lower cardiovascular events (incidents that may cause damage to the… (low certainty).
1 finding from 1 review
Intervention not reported
Renal failure (number of individuals with an elevation of serum creatinine greater than 2 mg/dL or requiring dialysis)
The intervention showed no clear difference in renal failure (number of individuals with an elevation of serum… (low certainty).
1 finding from 1 review
Intervention not reported
Length of ICU stay (days admitted to the ICU unit)
1 finding from 1 review
Intervention not reported
Length of hospital stay (days admitted to the hospital)
1 finding from 1 review
Intervention not reported
Postoperative pancreatic fistula (grade B or C) · people undergoing distal pancreatectomy
The intervention showed no clear difference in postoperative pancreatic fistula (grade B or C) (low certainty).
1 finding from 1 review
Intervention not reported
Overall postoperative morbidity · people undergoing pancreaticoduodenectomy
1 finding from 1 review
Intervention not reported
Reoperation rate · people undergoing pancreaticoduodenectomy
It is very uncertain whether the intervention changes reoperation rate (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · people undergoing pancreaticoduodenectomy
1 finding from 1 review
Intervention not reported
Total hospital cost (US dollars) · people undergoing pancreaticoduodenectomy
It is very uncertain whether the intervention changes total hospital cost (US dollars) (very low certainty).
1 finding from 1 review
Intervention not reported
Total length of hospital stay (days) · people undergoing pancreaticoduodenectomy
The intervention showed no clear difference in total length of hospital stay (days) (low certainty).
1 finding from 1 review
Intervention not reported
Postoperative pancreatic fistula (grade B or C) · people undergoing pancreaticoduodenectomy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found